Riskpilot← Back to searchSign inGet full accessNaturkur Global AB
ABActiveOrg 5593110850Järnvägsgatan 36Other non-specialised retail sale · NACE 4712Est. 20210 employees
Revenue 2024
SEK 0
EBITDA margin
—
+79% vs 2023
Equity ratio
83.8%
Financial strength
Net profit 2024
SEK -9K
+79% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -9K | +79% |
| Net profit | SEK -9K | +79% |
| Total assets | SEK 37K | +56% |
| Equity | SEK 31K | -22% |
| Employees | 0 | — |
Legal name
Naturkur Global AB
Org number
5593110850
Legal form
Aktiebolag
NACE code
4712 · Other non-specialised retail sale
Founded
9 april 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten Styrelsen ska bestå av 2 styrelseledamöter och 1 styrelsesuppleant.
Company purpose
Bolaget ska bedriva verksamhet med partihandel med livsmedel och vitaminer och mineraler i form av kosttillskott på webben som i butik. Bolaget ska därtill erbjuda hälsorådgivning och diverse hälsotester och hälsoprover. Därutöver ska bolaget i sin verksamhet idka därmed förenlig verksamhet.
Address
Järnvägsgatan 36
Email
jean@cre8one.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 47 | 0 | 0 | 0 |
| Staff expenses | — | −0 | −3 | — |
| EBITDA | 2 | −24 | −43 | −9 |
| Depreciation & amort. | −0 | — | — | −0 |
| EBIT | 2 | −24 | −43 | −9 |
| Net financials | — | −0 | −0 | — |
| Profit before tax | 2 | −24 | −43 | −9 |
| Tax | −0 | — | — | −0 |
| Net profit | 2 | −24 | −43 | −9 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 39 | 59 | 24 | 37 |
| Equity | 27 | 53 | 40 | 31 |
| Long-term debt | 6 | 6 | 6 | 0 |
| Short-term debt | 7 | 0 | −22 | 6 |
| Total debt | 13 | 6 | −16 | 6 |
EBITDA margin
-900000.0%
This company
15.8%
Market median
-5696303% vs market
20212024
Equity ratio
83.8%
This company
38.2%
Market median
+119% vs market
20212024
Return on equity
-29.0%
This company
18.4%
Market median
-258% vs market
20212024
Net profit margin
-900000.0%
This company
8.1%
Market median
-11111211% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-04-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
GG Chief Executive Officer | Chief Executive Officer | 2025 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Deputy Board Member | 2025 | |
| Former (3) | ||
| Chairman | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2025 | |
| Board of Directors | 2021 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Naturkur Global AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gabriella Gunilla Samuels | Chief Executive Officer | 0 companies |
| Nils Johan Torsten Nilsson | Chairman | 0 companies |
| Sabri Jean Haddad | Chairman | 0 companies |
| Albert Ercan | Deputy Board Member | 0 companies |
| Sanna Inga Lovisa Asp | Deputy Board Member | 0 companies |
| Kennedi Samuels | Board of Directors | 0 companies |